GPC3 and cancer: In this study, we identified that circulating miR-375-3p, miR-193a-5p, and miR-1228-5p have potential as predictive biomarkers of response to GPC3 peptide vaccine therapy, and these three miRNAs are not broadly upregulated in cancer tissue.